A controlled study of donor blood shows serum-free media match serum-containing counterparts across PBMC isolation, ...
The VENTANA BAP1 (SP527) test helps confidently distinguish malignant mesothelioma from lung, breast and stomach cancers, as well as benign tissue growth in the chest or abdomen.
New research by the Medicines and Healthcare products Regulatory Agency (MHRA) in partnership with the GSK Vaccines Institute ...
Deep Mito brine assays strengthen Pursuit's case for a bigger Rio Grande Sur resource. ... Read More The post Pursuit ...
AnteoTech (ASX:ADO) is classified by the Australian Securities Exchange as a materials company but part of its offering sits ...
Mabtech AB, a Swedish developer of immunoassays and instruments for life science research, today announced that its complete product ...
A new mass spectrometry assay identifies patient-specific M-protein peptides in plasma without sequencing, showing generally ...
Nautilus Biotechnology (NASDAQ:NAUT) reported third-quarter revenue of $200,000 as it continued its transition toward ...
A new platform, developed by researchers at the Center for Computational Sciences, University of Tsukuba, in collaboration ...
The cobas smart e immunoanalyser – the newest addition to Roche’s industry-leading cobas immunoassay systems portfolio – is ...
MammoLink joins Mammogen’s KATELYN-ERIN trial, expanding community access to a prospective study evaluating blood-based RNA biology for breast cancer detection ...
Revolune today announced a partnership with Concept Life Sciences to help biopharma and life sciences customers reassess, transfer, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results